Public filings / TSHA on Yahoo Finance (opens in a new tab)
TSHA: who owns it, insider trades, analyst moves
Taysha Gene Therapies Inc - US
A summary of public filings about Taysha Gene Therapies Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · dated snapshot
Reported holdings for TSHA
6 rows in loaded coverage. Historical filing values, not current holdings or prices. Related managers may overlap; mappings and share comparisons remain unvalidated. Last successful refresh: 2026-11-11 20:50 ET.
| Reporting manager | Holdings as of | Reported value | Reported-universe weight |
|---|---|---|---|
| Avoro Capital Advisors | 2026-06-30 | $162,683,327 | 1.46% |
| Baker Bros. Advisors | 2026-06-30 | $27,272,388 | 0.14% |
| Farallon Capital | 2026-06-30 | $15,322,500 | 0.09% |
| Polen Capital | 2026-06-30 | $3,331,581 | 0.03% |
| RA Capital | 2026-06-30 | $160,413,963 | 1.39% |
| RTW Investments | 2026-06-30 | $92,345,357 | 0.79% |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.
